Healthcare Analytics News December 13, 2018
A report by the U.S. Food and Drug Administration (FDA) found that the benefits of digital health tools that are not regulated by the agency outweigh the risks.
FDA Commissioner Scott Gottlieb, M.D., said that there are many digital health products that people are using to track their wellness and health information that are not regulated by the agency. The report touches on tools such as e-prescribing software and mindfulness apps.
The FDA looked at information about the non-device software functions and how the functions impact patient safety.
>> READ: FDA Releases New Data Integrity Guidance to Improve Drug Quality
“In general, the FDA’s analysis found more benefits than risks to patient safety and health from the use of these...
Today's Sponsors
Today's Sponsor